1883816-50-9

Met-RANTES (human) Chemical Structure
1883816-50-9

Chemical Structure

Met-RANTES (human)

Synonym(s): MSPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSN

  • CAS No.: 1883816-50-9
  • Formula:C355H543N97O101S6
  • Molecular Weight:7978.07

SMILES: O=C([C@@H](N)CCSC)N[C@H](C(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N3[C@H](C(N[C@H](C(N4[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H]5CCCCN)=O)=O)CO)=O)[C@@H](C)O)=O)CC6=CC=C(O)C=C6)=O)CC7=CC=CC=C7)=O)CC8=CC=C(O)C=C8)=O)CCC(O)=O)=O)CCCCN)=O)[C@H](CC)C)=O)CC9=CNC=N9)=O)C)=O)CCCNC(N)=N)=O)CCC4)=O)CC(C)C)=O)CCC3)=O)CCCNC(N)=N)=O)C)=O)[C@H](CC)C)=O)CC%10=CC=C(O)C=C%10)=O)C)=O)CC%11=CC=CC=C%11)=O)CSSC[C@H](NC%12=O)C(N[C@H](C(N[C@H](C(N%13[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CO)=O)CCSC)=O)CCC(O)=O)=O)CC(C)C)=O)CO)=O)CC(N)=O)=O)[C@H](CC)C)=O)CC%14=CC=C(O)C=C%14)=O)CCC(O)=O)=O)CCCNC(N)=N)=O)C(C)C)=O)CC%15=CNC%16=CC=CC=C%15%16)=O)CCCCN)=O)CCCCN)=O)CCC(O)=O)=O)CCC%13)=O)CC(N)=O)=O)C)=O)=O)CSSC[C@H](NC5=O)C(N[C@H](C(N[C@H](C(N%17[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]%12C(C)C)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CC(N)=O)=O)CCCCN)=O)CCCNC(N)=N)=O)[C@@H](C)O)=O)C(C)C)=O)CC%18=CC=CC=C%18)=O)C(C)C)=O)C(C)C)=O)C)=O)CCC%17)=O)CC(N)=O)=O)CO)=O)=O)CCC2)=O)[C@@H](C)O)=O)[C@@H](C)O)=O)CC(O)=O)=O)CO)=O)CO)=O)CC%19=CC=C(O)C=C%19)=O)CCC1)=O)CO

Biological Activity: Met-RANTES (human) is the antagonist for CCR1 and CCR5. Met-RANTES (human) inhibits chemokines human MIP-1α and MIP-1β with IC50 of 5 and 2 nM. Met-RANTES (human) reduces bone destruction and ameliorates rats adjuvant-induced arthritis (AIA)[1].

Cat. No. Product Name Purity Description Pricing
HY-P4191
Met-RANTES (human) Met-RANTES (human) is the antagonist for CCR1 and CCR5. Met-RANTES (human) inhibits chemokines human MIP-1α and MIP-1β with IC50 of 5 and 2 nM. Met-RANTES (human) reduces bone destruction and ameliorates rats adjuvant-induced arthritis (AIA).
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide

References